The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19
Recruiting
Observational Study
Pulmonary Complications
Cardiovascular Complications
Renal Complications
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 345 (estimated)
- Sponsor
- Hellenic Institute for the Study of Sepsis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
More than 660 million cases of COVID-19 have been reported worldwide, with 183 million cases in the EU alone. In several people, after recovery, the effects of the first waves of COVID-19 persisted beyond the acute phase and increased the risk of chronic multiorgan symptoms and disease. Up to 70% of people affected by COVID-19 showed reduced organ function even four months or more after COVID-19 d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Group A (comparators)
1. Adults (18 years or more) of both genders
2. Negative history of acute COVID-19
Group B (patients with ΝΟ dysfunction)
1. Adults (18 years or more) of both genders
2. History of acute COVID-19 hospitalized or non-hospitalized. All cases appearing from…
Contacts